$SLNO
SOLENO THERAPEUTICS INC

2016 Q3 Form 10-Q Financial Statement

#000162828016018997 Filed on August 12, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $329.0K $2.000K $97.00K
YoY Change 33.2% -97.94%
Cost Of Revenue $399.0K $51.00K $22.00K
YoY Change 612.5% 131.82%
Gross Profit -$70.00K -$49.00K $75.00K
YoY Change -136.65% -165.33%
Gross Profit Margin -21.28% -2450.0% 77.32%
Selling, General & Admin $1.260M $1.588M $1.938M
YoY Change -42.23% -18.06% 155.67%
% of Gross Profit 2584.0%
Research & Development $708.0K $658.0K $1.181M
YoY Change -40.65% -44.28% 115.12%
% of Gross Profit 1574.67%
Depreciation & Amortization $30.00K $40.00K $10.00K
YoY Change 0.0% 300.0%
% of Gross Profit 13.33%
Operating Expenses $1.968M $2.246M $3.119M
YoY Change -41.67% -27.99% 138.64%
Operating Profit -$1.968M -$2.295M -$3.044M
YoY Change -38.17% -24.61% 132.9%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $191.0K -$72.00K $4.925M
YoY Change -273.64% -101.46% -431.43%
Pretax Income -$1.780M -$1.570M $1.880M
YoY Change -45.9% -183.51% -167.38%
Income Tax
% Of Pretax Income
Net Earnings -$2.750M -$3.513M $1.881M
YoY Change -16.49% -286.76% -167.35%
Net Earnings / Revenue -835.87% -175650.0% 1939.18%
Basic Earnings Per Share -$0.23 $0.25
Diluted Earnings Per Share -$873.0K -$0.23 $0.25
COMMON SHARES
Basic Shares Outstanding 15.76M shares 15.53M shares 7.518M shares
Diluted Shares Outstanding 15.53M shares 7.631M shares

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.420M $2.500M $7.530M
YoY Change 14.83% -66.8% 522.31%
Cash & Equivalents $5.415M $2.502M $7.530M
Short-Term Investments
Other Short-Term Assets $260.0K $200.0K $350.0K
YoY Change -23.53% -42.86% 66.67%
Inventory $703.0K $774.0K $277.0K
Prepaid Expenses
Receivables $137.0K $288.0K $12.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.507M $3.756M $8.165M
YoY Change 17.75% -54.0% 470.98%
LONG-TERM ASSETS
Property, Plant & Equipment $116.0K $118.0K $43.00K
YoY Change 18.37% 174.42% 7.5%
Goodwill $718.0K $718.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $126.0K $76.00K
YoY Change
Total Long-Term Assets $1.802M $1.779M $605.0K
YoY Change 2.27% 194.05% -15.97%
TOTAL ASSETS
Total Short-Term Assets $6.507M $3.756M $8.165M
Total Long-Term Assets $1.802M $1.779M $605.0K
Total Assets $8.309M $5.535M $8.770M
YoY Change 14.01% -36.89% 307.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $862.0K $957.0K $989.0K
YoY Change -9.55% -3.24% 54.53%
Accrued Expenses $920.0K $940.0K $1.220M
YoY Change -24.59% -22.95% 248.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.777M $1.901M $13.35M
YoY Change -70.52% -85.76% 1248.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $196.0K $200.0K $3.050M
YoY Change 29.8% -93.44% -82.56%
Total Long-Term Liabilities $196.0K $200.0K $3.053M
YoY Change -92.32% -93.45% -82.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.777M $1.901M $13.35M
Total Long-Term Liabilities $196.0K $200.0K $3.053M
Total Liabilities $1.973M $2.101M $16.40M
YoY Change -77.0% -87.19% -11.2%
SHAREHOLDERS EQUITY
Retained Earnings -$95.70M -$92.95M -$80.11M
YoY Change 14.74% 16.03%
Common Stock $101.4M $95.56M $72.48M
YoY Change 23.5% 31.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.712M $2.610M -$7.632M
YoY Change
Total Liabilities & Shareholders Equity $8.309M $5.535M $8.770M
YoY Change 14.01% -36.89% 307.91%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$2.750M -$3.513M $1.881M
YoY Change -16.49% -286.76% -167.35%
Depreciation, Depletion And Amortization $30.00K $40.00K $10.00K
YoY Change 0.0% 300.0%
Cash From Operating Activities -$2.790M -$4.040M -$2.250M
YoY Change -2.45% 79.56% 93.97%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$20.00K -$20.00K
YoY Change -100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$20.00K
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 -$20.00K -$30.00K
YoY Change -100.0% -33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.700M 70.00K 280.0K
YoY Change 335.11% -75.0% -82.61%
NET CHANGE
Cash From Operating Activities -2.790M -4.040M -2.250M
Cash From Investing Activities 0.000 -20.00K -30.00K
Cash From Financing Activities 5.700M 70.00K 280.0K
Net Change In Cash 2.910M -3.990M -2.000M
YoY Change -203.56% 99.5% -544.44%
FREE CASH FLOW
Cash From Operating Activities -$2.790M -$4.040M -$2.250M
Capital Expenditures $0.00 -$20.00K -$20.00K
Free Cash Flow -$2.790M -$4.020M -$2.230M
YoY Change 4.1% 80.27% 92.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 capn Additional Operating Lease Office Space
AdditionalOperatingLeaseOfficeSpace
5265 sqft
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
957000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
156000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
288000 USD
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1634000 USD
CY2016Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
944000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
89456000 USD
CY2015Q4 us-gaap Assets
Assets
8201000 USD
capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
1249000 USD
capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-1123000 USD
capn Classof Warrant Or Right Liquidated Damages Amount Percentof Volume Weighted Average Price
ClassofWarrantOrRightLiquidatedDamagesAmountPercentofVolumeWeightedAveragePrice
0.01
CY2015Q1 capn Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P2Y
CY2015Q3 capn Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P3Y
capn Noncash Transaction Exerciseof Warrants
NoncashTransactionExerciseofWarrants
13000 USD
capn Noncash Transaction Exerciseof Warrants
NoncashTransactionExerciseofWarrants
0 USD
capn Reduction In Initial Public Offering Costs Payable
ReductionInInitialPublicOfferingCostsPayable
45000 USD
capn Reduction In Initial Public Offering Costs Payable
ReductionInInitialPublicOfferingCostsPayable
0 USD
CY2016Q2 capn Working Capital
WorkingCapital
1900000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001484565
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15761530 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
Capnia, Inc.
dei Trading Symbol
TradingSymbol
CAPN
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
695000 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
95543000 USD
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
201000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
602000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
218000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
354000 USD
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8171 sqft
CY2016Q2 us-gaap Assets
Assets
5535000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
6404000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
3756000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
27000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
450000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7957000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7530000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5495000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2502000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-427000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2993000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14017909 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15761530 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14017909 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15761530 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
14000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
15000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2220000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
22000 USD
us-gaap Cost Of Revenue
CostOfRevenue
40000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
428000 USD
us-gaap Cost Of Revenue
CostOfRevenue
889000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
31000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
55000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.35
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4925000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1249000 USD
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
47000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1123000 USD
CY2015Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2016Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-94000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1432000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2718000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1509000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3449000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
718000 USD
CY2016Q2 us-gaap Goodwill
Goodwill
718000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
75000 USD
us-gaap Gross Profit
GrossProfit
79000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-37000 USD
us-gaap Gross Profit
GrossProfit
-51000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
401000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
334000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3050000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
CY2016Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
257000 USD
us-gaap Inventory Write Down
InventoryWriteDown
70000 USD
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
132000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
617000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-689000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
169000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
223000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
64000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
59000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
15000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2015Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
480147000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
193853000 shares
CY2015Q2 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
1000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
46000 USD
CY2016Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
147000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
551000 USD
CY2016Q2 us-gaap Inventory Net
InventoryNet
774000 USD
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106000 USD
CY2016Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
370000 USD
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
399000 USD
CY2015Q3 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P4Y
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8201000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5535000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3194000 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1901000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3664000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5070000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4060000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8024000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
1881000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9770000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-3513000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6702000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
3119000 USD
us-gaap Operating Expenses
OperatingExpenses
5549000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
3413000 USD
us-gaap Operating Expenses
OperatingExpenses
7662000 USD
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3044000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5470000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3450000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7713000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23300 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
114000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
325000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000 USD
CY2015Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
917000 USD
CY2016Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
867000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
109000 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4925000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4300000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-63000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1011000 USD
CY2015Q2 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0 USD
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0 USD
CY2016Q2 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
16000 USD
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
18000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
530000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39000 USD
CY2015Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0 USD
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
3050000 USD
CY2016Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
167000 USD
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
157000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5071000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
294000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
70000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
102000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1181000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2059000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1327000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3098000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86247000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92948000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
97000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
119000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
391000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
838000 USD
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
506000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
772000 USD
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
577000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1115000 USD
us-gaap Stock Issued1
StockIssued1
112000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
3223000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
2610000 USD
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7630644 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7243164 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15528922 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15162520 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7517794 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7243164 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15528922 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15162520 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">estimates. Key estimates included in the financial statements include the valuation of: deferred income tax assets, liability and equity instruments, stock-based compensation, acquired intangibles, contingent earn-out consideration, and allowances for accounts receivable and inventory.</font></div></div>

Files In Submission

Name View Source Status
0001628280-16-018997-index-headers.html Edgar Link pending
0001628280-16-018997-index.html Edgar Link pending
0001628280-16-018997.txt Edgar Link pending
0001628280-16-018997-xbrl.zip Edgar Link pending
capn-20160630.xml Edgar Link completed
capn-20160630.xsd Edgar Link pending
capn-20160630x10q.htm Edgar Link pending
capn-20160630_cal.xml Edgar Link unprocessable
capn-20160630_def.xml Edgar Link unprocessable
capn-20160630_lab.xml Edgar Link unprocessable
capn-20160630_pre.xml Edgar Link unprocessable
ex-31120160630x10q.htm Edgar Link pending
ex-31220160630x10q.htm Edgar Link pending
ex-32120160630x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending